Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series.
Journal Information
Full Title: J Neurol Sci
Abbreviation: J Neurol Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosures Marcello Moccia has received honoraria from Ipsen, Merck, Roche and Sanofi-Genzyme; and research grants from ECTRIMS-MAGNIMS, UK MS Society, and Merck. Roberta Lanzillo has received honoraria from Almirall, Biogen, Merck, Novartis, Roche and Sanofi-Genzyme. Vincenzo Brescia Morra has received honoraria from Almirall, Bayer, Biogen, Merck, Novartis, Roche and Sanofi-Genzyme; and research grants from Italian MS Foundation. Other authors have nothing to disclose."
Funding Disclosure
Evidence found in paper:
"Funding The present study received no specific funding."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025